Since 2002, the Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
In this editorial published on April 26, 2019, Douglas Holtz-Eakin, economist and President of American Action Forum, questions economic truths about drug importation:
“Drug reimportation has long been the fool’s gold of health policy, and the Florida bill is no different. It flunks a basic policy analysis. But most amazing, it is drafted to raise hope, but not actually help Floridians.”
We recently ran an ad in Florida about the dangers of attempting to import medicine from Canada, and the risk of getting medicine from other countries like China where much of the world’s counterfeits come from. WESH 2 News serving Orlando put the ad through their exclusive Truth Test on April 25, 2019, and the claims in…
In this piece published in the Washington Free Beacon on April 25, 2019, staff writer Charles Fain Lehman explores issues around Florida’s drug importation proposal. “Critics,” he notes, “fear that the actual realities of regulatory oversight—especially in the hand of an as-yet-unnamed private vendor—will simply be too challenging to manage responsibly.”
In this piece, which was published in The Deseret News on April 24, 2019, pharmacist and Utah State Senate Majority Leader Evan Vickers raises serious concerns about importation as a strategy to lower drug prices:
“Anyone who truly understands how drugs are sold and distributed in the U.S. knows that there are very solid technical reasons that such importation is not viable. There are also serious concerns about drug safety, since the CHS cannot guarantee origin and purity on foreign-sourced drugs.”
In this piece, which was published on the ABC affiliate WJLA’s website on April 25, 2019, political analyst Boris Epshteyn explains that “this is a risky plan that will make it difficult to ensure that Floridians are receiving real and safe medicine.”
Politifact.com emailed us this week with questions about a recent ad about the dangers of attempting to import medicine from Canada. They labeled it negatively, but we noticed that they ignored certain facts while coming to their conclusion. In the interest of fairness, we’ve published below both the email from Politifact and our heavily sourced response. Judge for yourself if legislators in Florida are being naive about the risks of importation in a world with a highly evolved criminal counterfeit scheme.
Jacob Medina and his pregnant girlfriend, Diane Erika Marin, have been arrested in connection with a counterfeit pill distribution ring that is allegedly responsible for killing an Arkansas man, the KATV reports.
In this editorial, which was published in the Palm Beach Post on April 22, 2019, Michelle Flowers writes about Florida’s history of black market cancer treatments and the danger importation poses to patients. Flowers is president of the Oncology Managers of Florida.
The proposed legislation, H.R. 6554, will require that anyone who owns, purchases or imports pill press must be registered them with the U.S. Attorney General.
Tallahassee, FL (April 18, 2019) – Today the Partnership for Safe Medicines released new ads to run in several parts of Florida that highlight the dangers of Florida attempting to import medicine from Canada. Five different commissioners of the US Food and Drug Administration, appointed by both Republicans and Democrats, have stated that such proposals are dangerous to patients, will expose them to counterfeits, and are unlikely to reduce the price of medicine.